Literature DB >> 19595921

An estimate of the total worldwide societal costs of dementia in 2005.

Anders Wimo1, Bengt Winblad, Linus Jönsson.   

Abstract

BACKGROUND: The aim of this report was to estimate the worldwide cost of dementia in 2005 from a societal viewpoint.
METHODS: Costs were estimated by combining prevalence estimates, country and region specific data on Gross Domestic Product per person, and average wage with results from previously published cost-of-illness studies in different countries. Direct medical and nonmedical costs as well as costs for informal care were included.
RESULTS: The total worldwide societal cost of dementia, on the basis of a dementia population of 29.3 million persons, was estimated to be US$315.4 billion in 2005, including US$105 billion for informal care (33%). Seventy-seven percent of the total costs occurred in the more developed regions, with 46% of the prevalence.
CONCLUSIONS: Worldwide costs for dementia are enormous, and informal care constitutes a major cost component, in particular in less developed regions. The health economics of dementia is a highly relevant area for further research.

Entities:  

Year:  2007        PMID: 19595921     DOI: 10.1016/j.jalz.2007.02.001

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  70 in total

1.  Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study.

Authors:  A Gustavsson; L Jonsson; T Rapp; E Reynish; P J Ousset; S Andrieu; C Cantet; B Winblad; B Vellas; A Wimo
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  [Molecular principles of tau-induced toxicity: new experimental therapy strategies for treatment of Alzheimer's disease].

Authors:  A Schneider; P Falkai; A Papassotiropoulos
Journal:  Nervenarzt       Date:  2010-11       Impact factor: 1.214

3.  IPECAD5--Fifth International Pharmaco-Economic Conference on Alzheimer's Disease.

Authors:  A Gustavsson; L Jonsson; H Fillit; G Johansson; A Wimo; B Winblad
Journal:  J Nutr Health Aging       Date:  2010-05       Impact factor: 4.075

Review 4.  The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease.

Authors:  Jaclyn Cappell; Nathan Herrmann; Stephen Cornish; Krista L Lanctôt
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

5.  Nurses' perspectives on feeding decisions for nursing home residents with advanced dementia.

Authors:  Ruth Palan Lopez; Elaine J Amella; Susan L Mitchell; Neville E Strumpf
Journal:  J Clin Nurs       Date:  2010-03       Impact factor: 3.036

6.  Association of the spatial layout of the home and ADL abilities among older adults with dementia.

Authors:  Gesine Marquardt; Deirdre Johnston; Betty S Black; Ann Morrison; Adam Rosenblatt; Constantine G Lyketsos; Quincy M Samus
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-02       Impact factor: 2.035

7.  A Swedish programme for dementia diagnostics in primary healthcare.

Authors:  Erik Jedenius; Anders Wimo; Jan Strömqvist; Niels Andreasen
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

8.  Racial and ethnic disparities in the treatment of dementia among Medicare beneficiaries.

Authors:  Ilene H Zuckerman; Priscilla T Ryder; Linda Simoni-Wastila; Thomas Shaffer; Masayo Sato; Lirong Zhao; Bruce Stuart
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2008-09       Impact factor: 4.077

Review 9.  Packages of care for dementia in low- and middle-income countries.

Authors:  Martin J Prince; Daisy Acosta; Erico Castro-Costa; Jim Jackson; K S Shaji
Journal:  PLoS Med       Date:  2009-11-03       Impact factor: 11.069

10.  Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil.

Authors:  Cecilia M Persson; Asa K Wallin; Sten Levander; Lennart Minthon
Journal:  BMC Neurol       Date:  2009-02-10       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.